Keywords: king, guidance, predicts, eps, usa-based, pharmaceuticals, announced
King 2003 guidance predicts EPS of $1.66
Article | 08 July 2002
USA-based King Pharmaceuticals has announced its financial guidance for2003, in which it projects net sales for blockbuster drug Altace (ramipril) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
